Australia, Feb. 27 -- Fennec Pharmaceuticals Inc., owns the trademark (2467200) for 'PEDMARQSI' till July 18, 2034.
Status: registered:
Registered/protected
Class: 5 [Pharmaceutical preparations, namely, sodium thiosulfate used for the prevention of ototoxicity from cisplatin in pediatric patients]
Type of Mark: Word
Date of Acceptance: Aug. 28, 2024
Registration Advertised: Feb. 26
For further details contact Ashurst Australia.
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2467200.
Disclaimer: Curated by HT Syndication.
